We are monitoring the impact of COVID-19 on Kidney Cancer Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 785
Share on
Share on

Global Kidney Cancer Diagnostics and Therapeutics Market Analysis - By Type (Transitional Cell Cancer, Renal Cell Carcinoma, Renal Sarcoma, Others), By Tests (Biopsy, CT Scan, Cystoscopy, Intravenous Pyelogram, Kidney Ultrasound) and By Region - Industry Size, Share, Growth, Trends and Forecast | 2019 - 2024

Pulished: August, 2019
ID: 785
Pages: 178

Kidney Cancer Diagnostics and Therapeutics Market Size & Growth (2019 - 2024)

The size of the Global Kidney Cancer Diagnostics and Therapeutics Market was worth USD 3.47 billion in 2019 and estimated to be growing at a CAGR of 5.64%, to reach USD 4.57 billion by 2024.

Though there has been considerable development in science and technology to tackle cancer, it continues to threaten lives across the world. Kidney cancer is one of the frequent urologic tumors accounting for around 3% of all human cancers. The frequency rate of renal cell carcinoma has increased gradually in recent decades.

The primary factor which significantly boosting the growth of global kidney cancer diagnostics and therapeutics market is the increasing adoption of advanced therapy techniques such as cytokine-based treatment. The increasing economies of the various countries are helping the healthcare industry to grow at a high pace which is further contributing to the growth of global kidney cancer diagnostics and therapeutics market. Increasing demand for a novel and effective diagnostics and therapeutics is another major factor catalyzing the growth of the Global Kidney Cancer Diagnostics and Therapeutics Market. Also, increased investments from governments and private organizations for research and development to develop minimally invasive techniques, and the emergence of effective therapy procedures such as nephrectomy are boosting the growth in global kidney cancer diagnostics and therapeutics market.

The emergence of novel and innovative diagnostics and therapeutic procedures such as cytokine and nephrectomy are boosting the growth opportunities for key market players in this market, promoting growth during the forecast period across the world. Increasing prevalence of geriatric population and growing demand for extensive diagnostics tests are leading to the development and adoption of the novel therapy procedures which is creating a number of growth opportunities or the stakeholders operating in the global kidney cancer diagnostics and therapeutics market. An increasing number of research and development activities for kidney cancer diagnostics and the emergence of technically advanced tests are likely to expand growth opportunities for the key players functioning in the international marketplace.

High costs associated with branded cancer drugs are the major challenge that is limiting the growth of the worldwide market. The increasing adoption rate of generic drugs is another major challenge that is restricting the growth of global kidney cancer diagnostics and therapeutics market. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Tests and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A., Hoffmann La Roche, Novartis and Abbott Laboratories

 

This research report on the Global Kidney Cancer Diagnostics and Therapeutics Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Kidney Cancer Diagnostics and Therapeutics Market Analysis – By Type

  • Transitional Cell Cancer
  • Renal Cell Carcinoma
  • Renal Sarcoma

Kidney Cancer Diagnostics and Therapeutics Market Analysis – By Tests

  • Biopsy
  • CT Scan
  • Cystoscopy
  • Intravenous pyelogram
  • Kidney Ultrasound

Regional Analysis:

North America accounted for the largest share in the global Kidney Cancer Diagnostics and Therapeutics market followed by Asia-Pacific and Europe.  The frequency of this disease was higher in developed countries than in developing nations due to lifestyle factors. However, the Asia-Pacific region is anticipated to increase at the highest CAGR during the forecast period due to factors such as the low expense of drug production and the mounting patient base suffering from these diseases.

Key companies dominating the Global Kidney Cancer Diagnostics and Therapeutics Market profiled in this Market are:

  1. GlaxoSmithKline
  2. Bayer
  3. Pfizer
  4. Sanofi S.A
  5. Hoffmann La Roche
  6. Novartis
  7. Abbott Laboratories

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Type                     

                             5.1.1 Transitional Cell Cancer    

                             5.1.2 Renal cell carcinoma         

                             5.1.3 Renal sarcoma     

                             5.1.4 Other Cancers      

              5.2 By Tests                     

                             5.2.1 Biopsy      

                             5.2.2 CT Scan    

                             5.2.3 Cystoscopy            

                             5.2.4 Intravenous pyelogram    

                             5.2.5 Kidney Ultrasound             

6. Geographical Analysis                                         

              6.1 North America                       

                             6.1.1 Introduction         

                             6.1.2 United States        

                             6.1.3 Canada    

              6.2 Europe                      

                             6.2.1 Introduction         

                             6.2.2 U.K            

                             6.2.3 Spain        

                             6.2.4 Germany 

                             6.2.5 Italy          

                             6.2.6 France      

              6.3 Asia-Pacific               

                             6.3.1 Introduction         

                             6.3.2 China       

                             6.3.3 India         

                             6.3.4 Japan       

                             6.3.5 South Korea          

                             6.3.6 Australia  

              6.4 Latin America                         

                             6.4.1 Introduction         

                             6.4.2 Brazil        

                             6.4.3 Argentina

                             6.4.4 Mexico     

                             6.4.5 Rest of Latin America        

              6.5 Middle East & Africa                           

                             6.5.1 Introduction         

                             6.5.2 Middle-East          

                             6.5.3 Africa       

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8.Strategic Analysis                                    

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9.Market Leaders' Analysis                                     

              9.1 GlaxoSmithKline                    

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Bayer                         

              9.3 Pfizer                         

              9.4 Sanofi S.A                 

              9.5 Hoffmann La Roche              

              9.6 Novartis                    

              9.7 Abbott Laboratories                            

10.Competitive Landscape                                      

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11.Expert Opinions                                    

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  2. Global Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  3. Global Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  4. Global Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  5. Global Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  6. Global Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  7. Global Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  8. Global Biopsy Market By Region, From 2019-2024 (USD Billion)
  9. Global CT Scan Market By Region, From 2019-2024 (USD Billion)
  10. Global Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  11. Global Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  12. Global Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  13. North America Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  14. North America Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  15. North America Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  16. North America Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  17. North America Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  18. North America Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  19. North America Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  20. North America Biopsy Market By Region, From 2019-2024 (USD Billion)
  21. North America CT Scan Market By Region, From 2019-2024 (USD Billion)
  22. North America Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  23. North America Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  24. North America Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  25. United States Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  26. United States Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  27. Canada Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  28. Canada Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  29. Europe Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  30. Europe Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  31. Europe Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  32. Europe Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  33. Europe Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  34. Europe Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  35. Europe Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  36. Europe Biopsy Market By Region, From 2019-2024 (USD Billion)
  37. Europe CT Scan Market By Region, From 2019-2024 (USD Billion)
  38. Europe Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  39. Europe Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  40. Europe Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  41. U.K Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  42. U.K Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  43. Spain Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  44. Spain Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  45. Germany Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  46. Germany Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  47. Italy Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  48. Italy Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  49. France Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  50. France Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  51. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  52. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  53. Asia-Pacific Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  54. Asia-Pacific Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  55. Asia-Pacific Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  56. Asia-Pacific Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  57. Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  58. Asia-Pacific Biopsy Market By Region, From 2019-2024 (USD Billion)
  59. Asia-Pacific CT Scan Market By Region, From 2019-2024 (USD Billion)
  60. Asia-Pacific Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  61. Asia-Pacific Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  62. Asia-Pacific Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  63. China Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  64. China Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  65. India Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  66. India Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  67. Japan Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  68. Japan Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  69. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  70. South Korea Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  71. Australia Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  72. Australia Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  73. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  74. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  75. Latin America Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  76. Latin America Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  77. Latin America Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  78. Latin America Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  79. Latin America Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  80. Latin America Biopsy Market By Region, From 2019-2024 (USD Billion)
  81. Latin America CT Scan Market By Region, From 2019-2024 (USD Billion)
  82. Latin America Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  83. Latin America Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  84. Latin America Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  85. Brazil Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  86. Brazil Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  87. Argentina Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  88. Argentina Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  89. Mexico Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  90. Mexico Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  91. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Region, From 2019-2024 (USD Billion)
  92. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  93. Middle East & Africa Transitional Cell Cancer Market By Region, From 2019-2024 (USD Billion)
  94. Middle East & Africa Renal cell carcinoma Market By Region, From 2019-2024 (USD Billion)
  95. Middle East & Africa Renal sarcoma Market By Region, From 2019-2024 (USD Billion)
  96. Middle East & Africa Other Kidney Cancers Market By Region, From 2019-2024 (USD Billion)
  97. Middle East & Africa Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  98. Middle East & Africa Biopsy Market By Region, From 2019-2024 (USD Billion)
  99. Middle East & Africa CT Scan Market By Region, From 2019-2024 (USD Billion)
  100. Middle East & Africa Cystoscopy Market By Region, From 2019-2024 (USD Billion)
  101. Middle East & Africa Intravenous pyelogram Market By Region, From 2019-2024 (USD Billion)
  102. Middle East & Africa Kidney Ultrasound Market By Region, From 2019-2024 (USD Billion)
  103. Middle East Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  104. Middle East Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)
  105. Africa Kidney Cancer Diagnostics and Therapeutics Market By Type, From 2019-2024 (USD Billion)
  106. Africa Kidney Cancer Diagnostics and Therapeutics Market By Tests, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample